Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | glutathione-S-transferase/glutaredoxin, putative | 0.0289 | 0.5 | 0.5 |
Leishmania major | glutathione-S-transferase/glutaredoxin, putative | 0.0289 | 0.5 | 0.5 |
Toxoplasma gondii | prostaglandin-E synthase | 0.0289 | 0.5 | 0.5 |
Trypanosoma cruzi | glutathione-S-transferase/glutaredoxin, putative | 0.0289 | 0.5 | 0.5 |
Trypanosoma brucei | Prostaglandin E synthase | 0.0289 | 0.5 | 0.5 |
Onchocerca volvulus | 0.0289 | 0.5 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0289 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Adjuvant effect (functional) | Compound was tested for antibody titer in mice after injection with antigen in saline; compound is nonpyrogenic at 1 mg/kg | ChEMBL. | 6995612 | |
Anti-infectious effect (functional) | Compound was tested for protective activity in mice infected with Klebsiella pneumoniae; compound is nonpyrogenic at 1 mg/kg | ChEMBL. | 6995612 | |
Mitogenic effect (functional) | Compound was tested for [3H]- -thymidine uptake in mouse spleen cell cultures; compound is nonpyrogenic at 1 mg/kg | ChEMBL. | 6995612 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.